IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.770
+0.050 (2.91%)
At close: Mar 9, 2026, 4:00 PM EDT
1.700
-0.070 (-3.95%)
After-hours: Mar 9, 2026, 4:42 PM EDT
IN8bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 17 | 19 | 60 | 57 | 82 | - | |
| Market Cap Growth | -16.61% | -68.76% | 5.43% | -31.25% | - | - | |
| Enterprise Value | 9 | 20 | 52 | 34 | 44 | - | |
| Last Close Price | 1.72 | 7.72 | 41.40 | 69.30 | 131.70 | - | |
| PB Ratio | 0.60 | 1.29 | 2.39 | 2.49 | 2.16 | - | |
| P/TBV Ratio | 1.28 | 1.29 | 2.39 | 2.49 | 2.16 | - | |
| Debt / Equity Ratio | 0.22 | 0.35 | 0.20 | 0.26 | 0.06 | 0.01 | |
| Net Debt / Equity Ratio | -0.59 | -0.42 | -0.66 | -0.54 | -0.91 | -0.97 | |
| Net Debt / EBITDA Ratio | 0.40 | 0.22 | 0.57 | 0.44 | 2.47 | 2.10 | |
| Net Debt / FCF Ratio | 0.53 | 0.25 | 0.69 | 0.44 | 2.51 | 2.50 | |
| Quick Ratio | 6.28 | 3.61 | 3.95 | 3.12 | 16.41 | 7.00 | |
| Current Ratio | 6.91 | 4.08 | 4.57 | 3.82 | 17.28 | 7.05 | |
| Return on Equity (ROE) | -189.72% | -154.44% | -125.90% | -93.64% | -51.87% | -91.01% | |
| Return on Assets (ROA) | -80.39% | -67.70% | -56.81% | -47.37% | -29.01% | -48.53% | |
| Return on Capital Employed (ROCE) | -139.70% | -165.70% | -107.10% | -104.80% | -36.70% | -46.70% | |
| Earnings Yield | -122.27% | -163.26% | -50.29% | -50.39% | -17.80% | - | |
| FCF Yield | -86.62% | -130.54% | -40.12% | -49.16% | -16.78% | - | |
| Buyback Yield / Dilution | -127.93% | -79.30% | -42.43% | -110.32% | -191.59% | -7.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.